• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活动性类风湿疾病患者血清和滑液中氟比洛芬的浓度:一些初步观察结果。

Concentrations of flurbiprofen in serum and synovial fluid from patients with active rheumatoid disease: some preliminary observations.

作者信息

Chalmers T M, Glass R C, Risdall P C

出版信息

Curr Med Res Opin. 1977;5(1):17-20. doi: 10.1185/03007997709108970.

DOI:10.1185/03007997709108970
PMID:303167
Abstract

In 3 patients with active rheumatoid disease, concentrations of flurbiprofen of approximately 2 microgram per ml were achieved in synovial fluid 3 hours after a single oral dose of flurbiprofen (100 mg). The highest concentrations were seen between 3 and 9 hours after administration of the dose. The concentration of flurbiprofen in synovial fluid seemed to fall more slowly than in the circulation, but more extensive data would be needed to confirm this. In all 3 patients the drug was absorbed rapidly into the circulation, the highest serum concentrations of 7 microgram to 9 microgram per ml being seen in the first blood sample withdrawn 1.5 hours after administration of the dose. Serum concentrations fell with a mean apparent half-life of approximately 3 hours.

摘要

在3例活动性类风湿病患者中,单次口服氟比洛芬(100毫克)3小时后,滑液中氟比洛芬浓度达到约每毫升2微克。给药后3至9小时出现最高浓度。滑液中氟比洛芬浓度下降似乎比循环中更慢,但需要更多数据来证实这一点。在所有3例患者中,药物迅速吸收入循环,给药后1.5小时采集的第一份血样中血清最高浓度为每毫升7微克至9微克。血清浓度下降,平均表观半衰期约为3小时。

相似文献

1
Concentrations of flurbiprofen in serum and synovial fluid from patients with active rheumatoid disease: some preliminary observations.活动性类风湿疾病患者血清和滑液中氟比洛芬的浓度:一些初步观察结果。
Curr Med Res Opin. 1977;5(1):17-20. doi: 10.1185/03007997709108970.
2
Plasma and synovial fluid kinetics of flurbiprofen in rheumatoid arthritis.氟比洛芬在类风湿性关节炎中的血浆及滑液动力学
Br J Clin Pharmacol. 1986 Feb;21(2):155-63. doi: 10.1111/j.1365-2125.1986.tb05170.x.
3
The kinetics of flurbiprofen in synovial fluid.氟比洛芬在滑液中的动力学。
J Pharmacokinet Biopharm. 1991 Jun;19(3):265-9. doi: 10.1007/BF03036250.
4
Pharmacokinetics of flurbiprofen.
Am J Med. 1986 Mar 24;80(3A):10-5. doi: 10.1016/0002-9343(86)90104-x.
5
The pharmacokinetics of the enantiomers of flurbiprofen in patients with rheumatoid arthritis.氟比洛芬对映体在类风湿性关节炎患者中的药代动力学。
Br J Clin Pharmacol. 1991 Jan;31(1):102-4. doi: 10.1111/j.1365-2125.1991.tb03865.x.
6
Serum concentrations of flurbiprofen in rheumatoid patients receiving flurbiprofen over long periods of time.长期接受氟比洛芬治疗的类风湿患者的血清氟比洛芬浓度。
Curr Med Res Opin. 1977;5(1):21-5. doi: 10.1185/03007997709108971.
7
Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases.氟比洛芬:其药理学特性及在风湿性疾病中的治疗应用综述
Drugs. 1979 Dec;18(6):417-38. doi: 10.2165/00003495-197918060-00001.
8
Pharmacokinetics of lumiracoxib in plasma and synovial fluid.鲁米昔布在血浆和滑液中的药代动力学。
Clin Pharmacokinet. 2004;43(7):467-78. doi: 10.2165/00003088-200443070-00003.
9
Pharmacokinetics of flurbiprofen in man. I. Area/dose relationships.
Biopharm Drug Dispos. 1987 May-Jun;8(3):273-83. doi: 10.1002/bdd.2510080308.
10
Flurbiprofen-aspirin interaction: a double-blind crossover study.氟比洛芬-阿司匹林相互作用:一项双盲交叉研究。
Curr Med Res Opin. 1977;5(1):53-7. doi: 10.1185/03007997709108977.

引用本文的文献

1
Articular pharmacokinetics of protein-bound antirheumatic agents.蛋白结合型抗风湿药物的关节药代动力学。
Clin Pharmacokinet. 1993 Oct;25(4):342-50. doi: 10.2165/00003088-199325040-00007.
2
Clinical pharmacokinetics of flurbiprofen and its enantiomers.氟比洛芬及其对映体的临床药代动力学。
Clin Pharmacokinet. 1995 Feb;28(2):100-14. doi: 10.2165/00003088-199528020-00002.
3
Circadian variations in the signs and symptoms of rheumatoid arthritis and in the therapeutic effectiveness of flurbiprofen at different times of day.
类风湿关节炎的体征和症状的昼夜变化以及氟比洛芬在一天中不同时间的治疗效果。
Br J Clin Pharmacol. 1981 May;11(5):477-84. doi: 10.1111/j.1365-2125.1981.tb01153.x.
4
Diffusion of oxyphenbutazone into synovial fluid, synovial tissue, joint cartilage and cerebrospinal fluid.
Eur J Clin Pharmacol. 1983;25(1):107-12. doi: 10.1007/BF00544025.
5
Antirheumatic drug concentrations in human synovial fluid and synovial tissue. Observations on extravascular pharmacokinetics.人体滑液和滑膜组织中的抗风湿药物浓度。关于血管外药代动力学的观察。
Clin Pharmacokinet. 1983 Nov-Dec;8(6):496-522. doi: 10.2165/00003088-198308060-00002.
6
Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs.非甾体抗炎药的临床药代动力学
Clin Pharmacokinet. 1983 Jul-Aug;8(4):297-331. doi: 10.2165/00003088-198308040-00003.
7
Plasma and synovial fluid kinetics of flurbiprofen in rheumatoid arthritis.氟比洛芬在类风湿性关节炎中的血浆及滑液动力学
Br J Clin Pharmacol. 1986 Feb;21(2):155-63. doi: 10.1111/j.1365-2125.1986.tb05170.x.
8
The kinetics of flurbiprofen in synovial fluid.氟比洛芬在滑液中的动力学。
J Pharmacokinet Biopharm. 1991 Jun;19(3):265-9. doi: 10.1007/BF03036250.
9
A comparison of synovial fluid concentrations of non-steroidal anti-inflammatory drugs with their in vitro activity.非甾体抗炎药的滑液浓度与其体外活性的比较。
Agents Actions. 1991 Mar;32(3-4):261-5. doi: 10.1007/BF01980883.
10
Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases.氟比洛芬:其药理学特性及在风湿性疾病中的治疗应用综述
Drugs. 1979 Dec;18(6):417-38. doi: 10.2165/00003495-197918060-00001.